Related Experiment Video
Updated: Jul 19, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Fuzzy-based controller for glucose regulation in type-1 diabetic patients by subcutaneous route
D U Campos-Delgado1, M Hernández-Ordoñez, R Femat
1Universidad Autónoma de San Luis Potosí, Facultad de Ciencias, Av. Salvador Nava s/n, Zona Universitaria, C.P. 78290, S.L.P., México. ducd@fciencias.uaslp.mx
This study introduces a fuzzy logic control algorithm for type-1 diabetes management using multiple daily insulin injections. The system aims to precisely regulate blood glucose levels, adapting to individual patient dynamics for improved treatment outcomes.
Area of Science:
- Biomedical Engineering
- Control Systems Engineering
- Endocrinology
Background:
- Type-1 diabetes mellitus (TIDM) requires intensive insulin therapy for blood glucose level (BGL) regulation.
- Managing BGL variability in TIDM patients on multiple daily injections (MDIR) presents significant challenges.
- Existing control strategies often struggle to adapt to inter-patient physiological differences.
Purpose of the Study:
- To develop and evaluate an advisory/control algorithm for TIDM patients on MDIR.
- To enhance BGL regulation using expert knowledge embedded in fuzzy logic controllers.
- To address glucose-insulin dynamics variability through a robust two-loop feedback strategy.
Main Methods:
- Implementation of Mamdani-type fuzzy logic controllers for BGL regulation.
- Design of a two-loop feedback control architecture: an inner-loop for insulin dosing and an outer-loop for supervisory adjustment.
- Utilizing a detailed compartmental model of insulin-glucose dynamics for extensive closed-loop simulations.
Main Results:
- The proposed algorithm effectively regulates BGL in simulated TIDM patients.
- The two-loop strategy successfully compensates for patient-specific glucose-insulin dynamics variability.
- Fuzzy logic controllers demonstrated proficiency in managing rapid/short acting insulin (RSAI) and intermediate/long acting insulin (ILAI) delivery.
Conclusions:
- The developed fuzzy logic-based control algorithm offers a promising approach for TIDM management under MDIR.
- The supervisory outer-loop enhances the robustness and adaptability of the insulin delivery system.
- Simulation results support the clinical potential of this advanced BGL control strategy.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Hypoglycemia
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Hypoglycemia and Glucagon
Type I Diabetes I: Introduction
